![](/img/cover-not-exists.png)
519 POSTER A phase 2, single-arm study of volociximab (an anti-a5b1 integrin antibody) monotherapy in patients with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer
C.M. Matthews, S.N. Ho, M. Barve, K.M. Bell-McGuinn, L. Gilbert, R.T. Penson, E. Lengyel, S. Weymer, K. Gilder, R.J. SchilderVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72453-4
File:
PDF, 79 KB
english, 2008